We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+17.33%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.16B
AUM Growth
+$235M
Cap. Flow
+$21.9M
Cap. Flow %
1.01%
Top 10 Hldgs %
37.62%
Holding
102
New
26
Increased
22
Reduced
15
Closed
27

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$157M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$34.1M
3
NVRO
NEVRO CORP.
NVRO
+$28.6M
4
GILD icon
Gilead Sciences
GILD
+$28.1M
5
PEN icon
Penumbra
PEN
+$26.9M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$92.8M
2
MCK icon
McKesson
MCK
+$50.5M
3
CAH icon
Cardinal Health
CAH
+$45.2M
4
LH icon
Labcorp
LH
+$30.8M
5
BAX icon
Baxter International
BAX
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 67.91%
2 Technology 4.93%
3 Consumer Discretionary 1.42%
4 Industrials 0.78%
5 Utilities 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
26
Elevance Health
ELV
$84.8B
$27.8M 1.28%
103,455
+3,455
+3% +$930K
HRTX icon
27
Heron Therapeutics
HRTX
$95.5M
$27.7M 1.28%
1,872,012
-359,390
-16% -$5.61M
LH icon
28
Labcorp
LH
$25.4B
$27M 1.25%
166,828
-194,396
-54% -$30.8M
CNST
29
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$26.2M 1.21%
1,294,977
+243,587
+23% +$5.95M
AERI
30
DELISTED
Aerie Pharmaceuticals
AERI
$26.2M 1.21%
2,227,611
-46,609
-2% -$568K
MRTX
31
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$26.1M 1.21%
+157,100
New +$21.5M
BIIB icon
32
Biogen
BIIB
$30.5B
$25.5M 1.18%
+89,716
New +$25M
HSIC icon
33
Henry Schein
HSIC
$10.2B
$23.6M 1.09%
+402,310
New +$25.8M
ICLR icon
34
Icon
ICLR
$12.6B
$23.2M 1.07%
121,323
+18,357
+18% +$3.37M
XBI icon
35
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.99B
$22.3M 1.03%
200,000
-238,100
-54% -$26.7M
GILD icon
36
CALL
Gilead Sciences
GILD
$164B
$22.1M 1.02%
+350,000
New +$24.3M
BMRN icon
37
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
$21.8M 1.01%
+286,200
New +$29M
AZN icon
38
AstraZeneca
AZN
$250B
$21.3M 0.98%
193,950
-123,850
-39% -$13.8M
THC icon
39
Tenet Healthcare
THC
$21.1B
$20.6M 0.95%
841,194
+262,569
+45% +$6.71M
MSFT icon
40
Microsoft
MSFT
$3.62T
$20M 0.93%
95,177
– –
RVTY icon
41
Revvity
RVTY
$12.8B
$18.4M 0.85%
+147,000
New +$16.9M
HOLX
42
DELISTED
Hologic
HOLX
$18.1M 0.84%
272,193
-341,583
-56% -$21.6M
NXPI icon
43
NXP Semiconductors
NXPI
$58.3B
$18.1M 0.84%
144,881
+17,010
+13% +$2.08M
PFE icon
44
Pfizer
PFE
$147B
$17.6M 0.81%
+504,192
New +$17.7M
ACAD icon
45
Acadia Pharmaceuticals
ACAD
$4.93B
$17.4M 0.8%
+421,087
New +$18.2M
DE icon
46
Deere & Co
DE
$165B
$16.9M 0.78%
76,336
– –
AMZN icon
47
Amazon
AMZN
$2.94T
$16.8M 0.78%
106,840
– –
TRIL
48
DELISTED
Trillium Therapeutics Inc.
TRIL
$16M 0.74%
1,126,325
+271,055
+32% +$2.7M
TCRR
49
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$15.8M 0.73%
+775,794
New +$13.6M
NVDA icon
50
NVIDIA
NVDA
$5.31T
$14M 0.65%
1,036,440
-488,080
-32% -$5.68M
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return

PFM Health Sciences's Q3 2020 Portfolio in Review

As of Q3 2020, PFM Health Sciences held 102 positions worth $2.16B, up 12% from $1.93B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

PFM Health Sciences's Q3 2020 filing shows 26 new, 22 increased, 15 reduced and 27 closed positions. Its largest new stake was Outset Medical: 191,533 shares worth $131M. The largest sale was Immunomedics Inc, an estimated $92.8M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 67% a quarter earlier, followed by Technology and Consumer Discretionary.

  • PFM Health Sciences's largest Q3 2020 buy was Outset Medical: 191,533 shares worth $131M.
  • PFM Health Sciences added most to NEVRO CORP. in Q3 2020, an estimated $28.6M increase.
  • PFM Health Sciences's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $92.8M.
  • PFM Health Sciences fully exited McKesson in Q3 2020, selling an estimated $50.5M.
  • PFM Health Sciences's ten largest holdings make up 38% of its $2.16B portfolio in Q3 2020.
  • PFM Health Sciences opened 26 new positions and closed 27 in Q3 2020.
  • PFM Health Sciences's portfolio value rose 12% quarter-over-quarter to $2.16B.

Based on PFM Health Sciences's 13F filing for Q3 2020, filed 16 Nov 2020.